A rare complication of intravesical early instillation of mitomycin C after TURBT

The early intravesical Instillation of mitomycin C (MMC) is accepted as safe adjuvant therapy after TURBT by non-muscle- invasive bladder cancer if there is no perforation. In our case we report a female patient undergoing resection of papillary recurrent tumor on the anterior bladder wall. In the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatem, Humam, Leifeld, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616476/
https://www.ncbi.nlm.nih.gov/pubmed/31334032
http://dx.doi.org/10.1016/j.eucr.2019.100955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616476/
https://www.ncbi.nlm.nih.gov/pubmed/31334032
http://dx.doi.org/10.1016/j.eucr.2019.100955

Ejemplares similares